HEADER TRANSCRIPTION 15-MAY-15 4ZUB OBSLTE 16-NOV-16 4ZUB 5KCC TITLE CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN TITLE 2 COMPLEX WITH OXABICYCLIC HEPTENE SULFONAMIDE (OBHS-N) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, UNP RESIDUES 304-549; COMPND 5 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 11 CHAIN: C, D; COMPND 12 FRAGMENT: UNP RESIDUES 687-697; COMPND 13 SYNONYM: NCOA-2,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75,BHLHE75, COMPND 14 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2,HTIF2; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- KEYWDS 2 LIGAND COMPLEX, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.C.NWACHUKWU,S.SRINIVASAN,Y.ZHENG,S.WANG,J.MIN,C.DONG,Z.LIAO, AUTHOR 2 V.CAVETT,J.NOWAK,R.HOUTMAN,K.E.CARLSON,J.S.JOSAN,O.ELEMENTO, AUTHOR 3 J.A.KATZENELLENBOGEN,H.B.ZHOU,K.W.NETTLES REVDAT 2 16-NOV-16 4ZUB 1 OBSLTE REVDAT 1 01-JUN-16 4ZUB 0 JRNL AUTH J.C.NWACHUKWU,S.SRINIVASAN,Y.ZHENG,S.WANG,J.MIN,C.DONG, JRNL AUTH 2 Z.LIAO,V.CAVETT,J.NOWAK,R.HOUTMAN,K.E.CARLSON,J.S.JOSAN, JRNL AUTH 3 O.ELEMENTO,J.A.KATZENELLENBOGEN,H.B.ZHOU,K.W.NETTLES JRNL TITL PREDICTING PROLIFERATIVE EFFECTS OF ESTROGEN RECEPTOR JRNL TITL 2 LIGANDS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.5 REMARK 3 NUMBER OF REFLECTIONS : 16339 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1642 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.4743 - 5.4594 0.91 1342 146 0.2205 0.2594 REMARK 3 2 5.4594 - 4.3343 0.95 1383 158 0.2049 0.2509 REMARK 3 3 4.3343 - 3.7867 0.92 1343 137 0.1947 0.2351 REMARK 3 4 3.7867 - 3.4406 0.96 1355 162 0.2126 0.2352 REMARK 3 5 3.4406 - 3.1940 0.97 1400 153 0.2386 0.2444 REMARK 3 6 3.1940 - 3.0058 0.96 1366 159 0.2450 0.2944 REMARK 3 7 3.0058 - 2.8553 0.95 1367 144 0.2378 0.2727 REMARK 3 8 2.8553 - 2.7310 0.88 1240 143 0.2459 0.3162 REMARK 3 9 2.7310 - 2.6259 0.90 1277 146 0.2434 0.2805 REMARK 3 10 2.6259 - 2.5352 0.85 1215 126 0.2592 0.3095 REMARK 3 11 2.5352 - 2.4560 0.64 892 107 0.2614 0.3564 REMARK 3 12 2.4560 - 2.3860 0.36 517 61 0.2727 0.3548 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3881 REMARK 3 ANGLE : 0.562 5267 REMARK 3 CHIRALITY : 0.020 631 REMARK 3 PLANARITY : 0.002 651 REMARK 3 DIHEDRAL : 12.396 1402 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZUB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209919. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE I-BEAM REMARK 200 SINGLE CRYSTAL ASYMMETRIC CUT REMARK 200 4.965 DEGS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18649 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.14600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 0.86500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2QA8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 3350, 0.05M MGCL2, 0.067M REMARK 280 NACL, 0.1M TRIS, PH 8.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.58000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 304 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 LEU A 549 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 GLU B 471 REMARK 465 LYS B 472 REMARK 465 CYS B 530 REMARK 465 LYS B 531 REMARK 465 HIS C 687 REMARK 465 ASP D 696 REMARK 465 SER D 697 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 309 OG REMARK 470 PHE A 337 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 339 CG CD OE1 OE2 REMARK 470 VAL A 368 CG1 CG2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 GLU A 423 CG CD OE1 OE2 REMARK 470 LEU A 469 CG CD1 CD2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 ASP A 473 CG OD1 OD2 REMARK 470 LYS A 481 CG CD CE NZ REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 TYR A 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 SER A 527 OG REMARK 470 MET A 528 CG SD CE REMARK 470 LYS A 529 CG CD CE NZ REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 ASN A 532 CG OD1 ND2 REMARK 470 LEU A 536 CG CD1 CD2 REMARK 470 ARG A 548 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 304 CG OD1 ND2 REMARK 470 ASP B 321 CG OD1 OD2 REMARK 470 LYS B 416 CG CD CE NZ REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 ARG B 434 CG CD NE CZ NH1 NH2 REMARK 470 MET B 437 CG SD CE REMARK 470 THR B 460 OG1 CG2 REMARK 470 ASP B 473 CG OD1 OD2 REMARK 470 HIS B 476 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 529 CG CD CE NZ REMARK 470 ASN B 532 CG OD1 ND2 REMARK 470 ARG B 548 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 549 CG CD1 CD2 REMARK 470 ARG C 692 CG CD NE CZ NH1 NH2 REMARK 470 HIS D 687 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS A 529 N LYS A 531 1.99 REMARK 500 O HOH B 724 O HOH B 749 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 333 30.96 -71.80 REMARK 500 PHE A 337 139.81 71.43 REMARK 500 SER A 338 -153.66 -156.11 REMARK 500 PHE A 367 -54.09 54.98 REMARK 500 SER A 456 -73.26 -53.52 REMARK 500 LEU A 469 -98.96 -7.45 REMARK 500 SER A 527 -77.66 -56.51 REMARK 500 MET A 528 154.79 -41.73 REMARK 500 LYS A 529 -162.10 61.59 REMARK 500 CYS A 530 -48.31 46.42 REMARK 500 ASN A 532 64.57 7.72 REMARK 500 SER B 338 -163.38 -108.65 REMARK 500 MET B 438 20.93 -140.39 REMARK 500 SER B 456 -79.80 -56.33 REMARK 500 MET B 528 -1.78 -146.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 528 LYS A 529 -135.23 REMARK 500 CYS A 530 LYS A 531 143.52 REMARK 500 LYS A 531 ASN A 532 -124.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OB1 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OB1 B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PP6 RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH RESVERATROL REMARK 900 RELATED ID: 4ZN7 RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH REMARK 900 DIETHYLSTILBESTROL REMARK 900 RELATED ID: 4ZN9 RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC REMARK 900 HEPTENE SULFONATE REMARK 900 RELATED ID: 4ZNH RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-FLUORO- REMARK 900 SUBSTITUTED OBHS DERIVATIVE REMARK 900 RELATED ID: 4ZNS RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-FLUORO- REMARK 900 SUBSTITUTED OBHS DERIVATIVE REMARK 900 RELATED ID: 4ZNT RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-BROMO- REMARK 900 SUBSTITUTED OBHS DERIVATIVE REMARK 900 RELATED ID: 4ZNU RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHYL- REMARK 900 SUBSTITUTED OBHS DERIVATIVE REMARK 900 RELATED ID: 4ZNV RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHOXY- REMARK 900 SUBSTITUTED OBHS DERIVATIVE REMARK 900 RELATED ID: 4ZNW RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 4-BROMO- REMARK 900 SUBSTITUTED OBHS DERIVATIVE REMARK 900 RELATED ID: 4ZUC RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL REMARK 900 SUBSTITUTED OBHS-N DERIVATIVE REMARK 900 RELATED ID: 4ZWH RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL, REMARK 900 2-CHLOROBENZYL OBHS-N DERIVATIVE REMARK 900 RELATED ID: 4ZWK RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, REMARK 900 4-METHOXYBENZYL OBHS-N DERIVATIVE REMARK 900 RELATED ID: 5BNU RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, REMARK 900 4-CHLOROBENZYL OBHS-N DERIVATIVE REMARK 900 RELATED ID: 5BP6 RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, REMARK 900 ALPHA-NAPHTHYL OBHS-N DERIVATIVE REMARK 900 RELATED ID: 5BPR RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N- REMARK 900 TRIFLUOROETHYL OBHS-N DERIVATIVE REMARK 900 RELATED ID: 5BQ4 RELATED DB: PDB REMARK 900 ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N- REMARK 900 TRIFLUOROETHYL 4-CHLOROBENZYL OBHS-N DERIVATIVE DBREF 4ZUB A 304 549 UNP P03372 ESR1_HUMAN 304 549 DBREF 4ZUB B 304 549 UNP P03372 ESR1_HUMAN 304 549 DBREF 4ZUB C 687 697 UNP Q15596 NCOA2_HUMAN 687 697 DBREF 4ZUB D 687 697 UNP Q15596 NCOA2_HUMAN 687 697 SEQADV 4ZUB SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 4ZUB SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 246 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 A 246 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 A 246 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 A 246 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 A 246 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 A 246 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU CYS SEQRES 7 A 246 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 A 246 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 A 246 LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY SEQRES 10 A 246 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 A 246 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 A 246 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 A 246 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 A 246 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 A 246 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 A 246 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 A 246 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 A 246 LEU TYR SER MET LYS CYS LYS ASN VAL VAL PRO LEU SER SEQRES 19 A 246 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 1 B 246 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 B 246 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 B 246 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 B 246 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 B 246 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 B 246 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU CYS SEQRES 7 B 246 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 B 246 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 B 246 LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY SEQRES 10 B 246 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 B 246 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 B 246 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 B 246 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 B 246 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 B 246 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 B 246 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 B 246 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 B 246 LEU TYR SER MET LYS CYS LYS ASN VAL VAL PRO LEU SER SEQRES 19 B 246 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 1 C 11 HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SEQRES 1 D 11 HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER HET OB1 A 601 31 HET OB1 B 601 31 HETNAM OB1 (1S,2R,4S)-5,6-BIS(4-HYDROXYPHENYL)-N-PHENYL-7- HETNAM 2 OB1 OXABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONAMIDE FORMUL 5 OB1 2(C24 H21 N O5 S) FORMUL 7 HOH *104(H2 O) HELIX 1 AA1 SER A 305 LEU A 310 1 6 HELIX 2 AA2 THR A 311 ALA A 322 1 12 HELIX 3 AA3 SER A 338 LYS A 362 1 25 HELIX 4 AA4 THR A 371 SER A 395 1 25 HELIX 5 AA5 ASN A 413 VAL A 418 5 6 HELIX 6 AA6 GLY A 420 ASN A 439 1 20 HELIX 7 AA7 GLN A 441 SER A 456 1 16 HELIX 8 AA8 GLU A 470 ALA A 493 1 24 HELIX 9 AA9 THR A 496 MET A 528 1 33 HELIX 10 AB1 SER A 537 ALA A 546 1 10 HELIX 11 AB2 SER B 305 LEU B 310 1 6 HELIX 12 AB3 THR B 311 ALA B 322 1 12 HELIX 13 AB4 SER B 338 LYS B 362 1 25 HELIX 14 AB5 THR B 371 SER B 395 1 25 HELIX 15 AB6 ASN B 413 VAL B 418 5 6 HELIX 16 AB7 MET B 421 MET B 437 1 17 HELIX 17 AB8 GLN B 441 SER B 456 1 16 HELIX 18 AB9 HIS B 474 ALA B 493 1 20 HELIX 19 AC1 THR B 496 SER B 527 1 32 HELIX 20 AC2 SER B 537 ALA B 546 1 10 HELIX 21 AC3 HIS B 547 LEU B 549 5 3 HELIX 22 AC4 ILE C 689 ASP C 696 1 8 HELIX 23 AC5 LYS D 688 LEU D 694 1 7 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 SITE 1 AC1 10 LEU A 346 THR A 347 GLU A 353 LEU A 387 SITE 2 AC1 10 MET A 388 ARG A 394 MET A 421 ILE A 424 SITE 3 AC1 10 GLY A 521 HIS A 524 SITE 1 AC2 13 MET B 343 THR B 347 ALA B 350 GLU B 353 SITE 2 AC2 13 MET B 388 ARG B 394 VAL B 418 MET B 421 SITE 3 AC2 13 ILE B 424 GLY B 521 HIS B 524 LEU B 525 SITE 4 AC2 13 LEU B 540 CRYST1 54.530 81.160 58.680 90.00 110.80 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018339 0.000000 0.006966 0.00000 SCALE2 0.000000 0.012321 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018230 0.00000